Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Todeschini

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Histopathology|June 1, 1986
Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight casesF Menestrina, M Chilosi, F Bonetti, et al.
Leukemia|March 31, 1998
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicinG Todeschini, C Tecchio, V Meneghini, et al.
Cancer|July 1, 1993
Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcomeA Ambrosetti, G Nadali, F Vinante, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosisG Nadali, F Vinante, A Ambrosetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patientsG Todeschini, A Ambrosetti, V Meneghini, et al.
Blood|March 1, 1995
Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working PartyA Bacigalupo, G Broccia, G Corda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphomaG Nadali, F Vinante, H Stein, et al.
European Journal of Clinical Investigation|June 3, 1999
Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complicationsG Todeschini, C Murari, R Bonesi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 3, 2000
Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospitalR Luzzati, G Amalfitano, L Lazzarini, et al.
International Journal of Clinical & Laboratory Research|January 1, 1993
Soluble interleukin-2 receptor in hairy-cell leukemia: a reliable marker of diseaseA Ambrosetti, G Nadali, F Vinante, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Histopathology|June 1, 1986
Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight casesF Menestrina, M Chilosi, F Bonetti, et al.
Leukemia|March 31, 1998
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicinG Todeschini, C Tecchio, V Meneghini, et al.
Cancer|July 1, 1993
Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcomeA Ambrosetti, G Nadali, F Vinante, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosisG Nadali, F Vinante, A Ambrosetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patientsG Todeschini, A Ambrosetti, V Meneghini, et al.
Blood|March 1, 1995
Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working PartyA Bacigalupo, G Broccia, G Corda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphomaG Nadali, F Vinante, H Stein, et al.
European Journal of Clinical Investigation|June 3, 1999
Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complicationsG Todeschini, C Murari, R Bonesi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 3, 2000
Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospitalR Luzzati, G Amalfitano, L Lazzarini, et al.
International Journal of Clinical & Laboratory Research|January 1, 1993
Soluble interleukin-2 receptor in hairy-cell leukemia: a reliable marker of diseaseA Ambrosetti, G Nadali, F Vinante, et al.
Pageof 7